SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-164923
Filing Date
2021-05-18
Accepted
2021-05-18 11:48:45
Documents
2
Group Members
W. ALLEN CUSTARD IIIWILLIAM A. CUSTARD

Document Format Files

Seq Description Document Type Size
1 SC 13G d178150dsc13g.htm SC 13G 59686
2 EX-99.1 d178150dex991.htm EX-99.1 4246
  Complete submission text file 0001193125-21-164923.txt   65845
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Subject) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42217 | Film No.: 21934925
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4600 GREENVILLE AVENUE 3RD FLOOR DALLAS TX 75206
Business Address 4600 GREENVILLE AVENUE 3RD FLOOR DALLAS TX 75206 2142654315
Custard & Pitts Investment Co. LP (Filed by) CIK: 0001861866 (see all company filings)

IRS No.: 020672341 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G